Showing posts with label three. Show all posts
Showing posts with label three. Show all posts

Saturday 9 February 2019

The Impact Of Rituxan For The Treatment Of Follicular Lymphoma

The Impact Of Rituxan For The Treatment Of Follicular Lymphoma.
New inspect provides more testify that treating certain lymphoma patients with an valuable drug over the long term helps them go longer without symptoms. But the drug, called rituximab (Rituxan), does not seem to significantly widen life span, raising questions about whether it's worth taking. People with lymphoma who are looking at maintenance treatment "really need a discussion with their oncologist," said Dr Steven T Rosen, number one of the Robert H Lurie Comprehensive Cancer Center at Northwestern University in Chicago get the facts. The cramming involved people with follicular lymphoma, one of the milder forms of non-Hodgkin lymphoma, a length of time that refers to cancers of the immune system.

Though it can be fatal, most commonalty live for at least 10 years after diagnosis. There has been debate over whether people with the disease should consider Rituxan as maintenance therapy after their initial chemotherapy. In the study, which was funded in part by F Hoffmann-La Roche, a pharmaceutical troop that sells Rituxan, roughly half of the 1019 participants took Rituxan, and the others did not neosizexlusa.shop. All in days of old had taken the drug right after receiving chemotherapy.

In the next three years, the swotting found, people taking the drug took longer, on average, to come out symptoms. Three-quarters of them made it to the three-year mark without progression of their illness, compared with about 58 percent of those who didn't lay the drug. But the death rate over three years remained about the same, according to the report, published online Dec 21 2010 in The Lancet.

Saturday 8 December 2018

New Research In The Treatment Of Cancer Of Immune System

New Research In The Treatment Of Cancer Of Immune System.
New on provides more sign that treating certain lymphoma patients with an extravagant drug over the long term helps them go longer without symptoms. But the drug, called rituximab (Rituxan), does not seem to significantly burgeon life span, raising questions about whether it's worth taking. People with lymphoma who are inasmuch as maintenance treatment "really need a discussion with their oncologist," said Dr Steven T Rosen, chief of the Robert H Lurie Comprehensive Cancer Center at Northwestern University in Chicago sesy bhabi oil ki malish sistr se. The learning involved people with follicular lymphoma, one of the milder forms of non-Hodgkin lymphoma, a nickname that refers to cancers of the immune system.

Though it can be fatal, most citizenry live for at least 10 years after diagnosis. There has been debate over whether people with the disease should make use of Rituxan as maintenance therapy after their initial chemotherapy. In the study, which was funded in part by F Hoffmann-La Roche, a pharmaceutical players that sells Rituxan, roughly half of the 1,019 participants took Rituxan, and the others did not aguaje. All theretofore had taken the drug right after receiving chemotherapy.

In the next three years, the survey found, people taking the drug took longer, on average, to age symptoms. Three-quarters of them made it to the three-year mark without progression of their illness, compared with about 58 percent of those who didn't consume the drug. But the death rate over three years remained about the same, according to the report, published online Dec 21 2010 in The Lancet.

Tuesday 13 March 2018

Some Elderly Men Really Suffer From Andropause, But Much Less Frequently Than Previously Thought

Some Elderly Men Really Suffer From Andropause, But Much Less Frequently Than Previously Thought.
In describing a set of substantial symptoms for "male menopause" for the basic time, British researchers have also resolute that only about 2 percent of men venerable 40 to 80 suffer from the condition, far less than previously thought. Male menopause, also called "andropause" or late-onset hypogonadism, reputedly results from declines in testosterone production that occur later in life, but there has been some moot on how real the phenomenon is, the study authors noted vaginal. "Some aging men doubtless suffer from male menopause.

It is a genuine syndrome, but much less common than previously assumed," concluded Dr Ilpo Huhtaniemi, elder author of a study published online June 16 in the New England Journal of Medicine malayalam. "This is foremost because it demonstrates that genuine symptomatic androgen deficiencies androgens are man's hormones is less common than believed, and that only the right patients should get androgen treatment," added Huhtaniemi, a professor of reproductive endocrinology in the area of surgery and cancer at Imperial College London.

Many men have been taking testosterone supplements to joust the perceived effects of aging, even though it's not assured if taking these supplements help or if they're even safe. The result has been mass confusion, not only as to whether male menopause exists but also how to gift it. "A lot of people abuse testosterone who shouldn't and a lot of men who should get it aren't," said Dr Michael Hermans, an confederate professor of surgery in the Texas A&M Health Science Center College of Medicine and supervisor of the section of andrology, male sexual dysfunction and manly infertility at Scott & White in Temple, Texas.

Monday 16 October 2017

Alzheimer's Disease Against A Cancer

Alzheimer's Disease Against A Cancer.
Although a observe in 2012 suggested a cancer medication could reverse the thinking and memory problems associated with Alzheimer's disease, three groups of researchers now assert they have been unable to duplicate those findings. The teams said their scrutiny could have serious implications for patient safety since the drug involved in the study, bexarotene (Targretin), has grim side effects, such as major blood-lipid abnormalities, pancreatitis, headaches, fatigue, weight gain, depression, nausea, vomiting, constipation and rash proextenderusa com. "Anecdotally, we have all heard that physicians are treating their Alzheimer's patients with bexarotene, a cancer medicate with hard side effects," said study co-author Robert Vassar, a professor of apartment and molecular biology at Northwestern University Feinberg School of Medicine, in Chicago.

This profession should be ended immediately, given the failure of three independent research groups to replicate the plaque-lowering things of bexarotene. The US Food and Drug Administration approved bexarotene in 1999 to act toward refractory cutaneous T-cell lymphoma proextender ciudad acuГ±a price. Once approved, however, the antidepressant also was available by prescription for "off-label" uses.

The 2012 study suggested that bexarotene was able to right away reverse the build-up of beta amyloid plaques in the brains of mice. The authors of the opening study concluded that treatment with the drug might reverse the cognitive and memory problems associated with the incident of Alzheimer's. Sangram Sisodia, a professor of neurosciences at the University of Chicago and a study co-author of the modern development research, admitted being skeptical about the initial findings.

Friday 10 March 2017

Doctors Recommend A New Type Of Flu Vaccine

Doctors Recommend A New Type Of Flu Vaccine.
A vaccine that protects children against four strains of flu may be more operative than the usual three-strain vaccine, a budding scrutinize suggests. The four-strain (or so-called "quadrivalent") vaccine is available as a nasal spindrift or an injection for the first time this flu season. The injected version, however, may be in transient supply, according to the US Centers for Disease Control and Prevention skin care. The study of about 200 children did not correlate the four-strain vaccine to the traditional three-strain vaccine.

Rather, it looked at how kids responded either to the four-strain vaccine or a hepatitis A vaccine, and then compared retort rates for the four-strain flu vaccine to reply rates for the three-strain vaccine from last year's flu season make your own skin bleaching cream. "This is the before large, randomized, controlled trial to demonstrate the efficacy of a quadrivalent flu vaccine against influenza in children," said work co-author Dr Ghassan Dbaibo.

"The results showed that, by preventing sensible to severe influenza, vaccination achieved reductions of 61 percent to 77 percent in doctors' visits, hospitalizations, absences from seminary and parental absences from work," said Dbaibo, at the segment of pediatrics and adolescent medicine at the American University of Beirut Medical Center, in Lebanon. The results endorse the effectiveness of the vaccine against influenza, and particularly against moderate to painstaking influenza.

"They also showed an 80 percent reduction in lower respiratory tract infections, which is the most common bad outcome of influenza. Therefore, vaccination of children in this age group can help to reduce the significant millstone placed on parents, doctors and hospitals every flu season. The report was published online Dec 11, 2013 in the New England Journal of Medicine.

The ruminate on was funded by GlaxoSmithKline, maker of the four-strain vaccine worn in the study. Dr Lisa Grohskopf, a medical cop in CDC's influenza division, said there are several flu vaccine options for children. For children age-old 2 and up, a nasal spray is an option, and for children under 2, the usual injection is available. "The nasal vaporizer vaccine is a quadrivalent vaccine, which has four different flu viruses in it.

Monday 17 March 2014

Nutritionists Provide Recommendations About Food

Nutritionists Provide Recommendations About Food.
Healthier eating, losing majority and getting more annoy are among the most common New Year's resolutions, and it's important to make a organize and be patient to achieve these goals, an expert says Dec 2013. If you decide to opportunity eating healthier, it can be difficult to decide where to start. It's best to focus on specific changes to sort your goal more attainable, said Kelly Hogan, a clinical dietitian at Mount Sinai Hospital in New York City.

Here are some examples: Replace fried chicken or fish with baked or broiled versions two or three times a week; devour four or five servings of vegetables every weekday; and cook dinner at residence three nights a week a substitute of ordering carry-out food. Instead of raw out all your nightly desserts, plan to have one small dessert one or two nights per week.

Sunday 2 February 2014

Dialysis Six Times A Week For Some Patients Better Than Three

Dialysis Six Times A Week For Some Patients Better Than Three.
Kidney failing patients who double-barrelled the number of weekly dialysis treatments typically prescribed had significantly better sensitivity function, overall health and general quality of life, new scrutinization indicates. The finding stems from an analysis that compared the impact of the 40-year-old standard of concern - three dialysis treatments per week, for three to four hours per period - with a six-day a week treatment regimen involving sessions of 2,5 to three hours per session. Launched in 2006, the similarity involved 245 dialysis patients assigned to either a typical dialysis schedule or the high-frequency option. All participants underwent MRIs to assess pluck muscle structure, and all completed quality-of-life surveys.

In addition to improved cardiovascular healthfulness and overall health, the analysis further revealed that two concerns faced by most kidney failure patients - blood arm-twisting and phosphate level control - also fared better under the more frequent remedying program. Dr Glenn Chertow, chief of the nephrology division at Stanford University School of Medicine, reports his team's observations in the Nov 20, 2010 online copy of the New England Journal of Medicine, to co-occur with a presentation at the annual meeting of the American Society of Nephrology in Denver.

And "Kidneys function seven days a week, 24 hours a day," Chertow respected in a Stanford University news release. "You could imagine why people might feel better if dialysis were to more closely imitative kidney function. But you have to factor in the burden of additional sessions, the rove and the cost".